Adverse events for biologics in patients with CRSwNP: A meta-analysis

被引：11
作者：
Shen, Yang [1 ]
Ke, Xia [1 ]
Hong, Suling [1 ]
Yang, Yucheng [1 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
来源：
CLINICAL AND TRANSLATIONAL ALLERGY | 2022年 / 12卷 / 06期
基金：
中国国家自然科学基金;
关键词：
adverse event; biologics; chronic rhinosinusitis with nasal polyposis; meta-analysis; NASAL POLYPOSIS; MEPOLIZUMAB; EFFICACY; SAFETY;
D O I：
10.1002/clt2.12169
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 12 条
  • [1] Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma
    Agache, Ioana
    Beltran, Jessica
    Akdis, Cezmi
    Akdis, Mubeccel
    Canelo-Aybar, Carlos
    Canonica, Giorgio Walter
    Casale, Thomas
    Chivato, Tomas
    Corren, Jonathan
    Del Giacco, Stefano
    Eiwegger, Thomas
    Firinu, Davide
    Gern, James E.
    Hamelmann, Eckard
    Hanania, Nicola
    Makela, Mika
    Martin, Irene Hernandez
    Nair, Parameswaran
    O'Mahony, Liam
    Papadopoulos, Nikolaos G.
    Papi, Alberto
    Park, Hae-Sim
    Perez de Llano, Luis
    Posso, Margarita
    Rocha, Claudio
    Quirce, Santiago
    Sastre, Joaquin
    Shamji, Mohamed
    Song, Yang
    Steiner, Corinna
    Schwarze, Jurgen
    Alonso-Coello, Pablo
    Palomares, Oscar
    Jutel, Marek
    [J]. ALLERGY, 2020, 75 (05) : 1023 - 1042
  • [2] Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
    Bachert, Claus
    Han, Joseph K.
    Desrosiers, Martin
    Hellings, Peter W.
    Amin, Nikhil
    Lee, Stella E.
    Mullol, Joaquim
    Greos, Leon S.
    Bosso, John V.
    Laidlaw, Tanya M.
    Cervin, Anders U.
    Maspero, Jorge F.
    Hopkins, Claire
    Olze, Heidi
    Canonica, G. Walter
    Paggiaro, Pierluigi
    Cho, Seong H.
    Fokkens, Wytske J.
    Fujieda, Shigeharu
    Zhang, Mei
    Lu, Xin
    Fan, Chunpeng
    Draikiwicz, Steven
    Kamat, Siddhesh A.
    Khan, Asif
    Pirozzi, Gianluca
    Patel, Naimish
    Graham, Neil M. H.
    Ruddy, Marcella
    Staudinger, Heribert
    Weinreich, David
    Stahl, Neil
    Yancopoulos, George D.
    Mannent, Leda P.
    [J]. LANCET, 2019, 394 (10209) : 1638 - 1650
  • [3] Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial
    Bachert, Claus
    Mannent, Leda
    Naclerio, Robert M.
    Mullol, Joaquim
    Ferguson, Berrylin J.
    Gevaert, Philippe
    Hellings, Peter
    Jiao, Lixia
    Wang, Lin
    Evans, Robert R.
    Pirozzi, Gianluca
    Graham, Neil M.
    Swanson, Brian
    Hamilton, Jennifer D.
    Radin, Allen
    Gandhi, Namita A.
    Stahl, Neil
    Yancopoulos, George D.
    Sutherland, E. Rand
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (05): : 469 - 479
  • [4] Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
    Bachert, Claus
    Sousa, Ana R.
    Lund, Valerie J.
    Scadding, Glenis K.
    Gevaert, Philippe
    Nasser, Shuaib
    Durham, Stephen R.
    Cornet, Marjolein E.
    Kariyawasam, Harsha H.
    Gilbert, Jane
    Austin, Daren
    Maxwell, Aoife C.
    Marshall, Richard P.
    Fokkens, Wytske J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (04) : 1024 - +
  • [5] A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
    Flood-Page, Patrick
    Swenson, Cheri
    Faiferman, Isidore
    Matthews, John
    Williams, Michael
    Brannick, Lesley
    Robinson, Douglas
    Wenzel, Sally
    Busse, William
    Hansel, Trevor T.
    Barnes, Neil C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (11) : 1062 - 1071
  • [6] Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
    Gevaert, Philippe
    Omachi, Theodore A.
    Corren, Jonathan
    Mullol, Joaquim
    Han, Joseph
    Lee, Stella E.
    Kaufman, Derrick
    Ligueros-Saylan, Monica
    Howard, Monet
    Zhu, Rui
    Owen, Ryan
    Wong, Kit
    Islam, Lutaf
    Bachert, Claus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (03) : 595 - 605
  • [7] Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
    Gevaert, Philippe
    Calus, Lien
    Van Zele, Thibaut
    Blomme, Katrien
    De Ruyck, Natalie
    Bauters, Wouter
    Hellings, Peter
    Brusselle, Guy
    De Bacquer, Dirk
    van Cauwenberge, Paul
    Bachert, Claus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (01) : 110 - U166
  • [8] Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
    Gevaert, Philippe
    Van Bruaene, Nicholas
    Cattaert, Tom
    Van Steen, Kristel
    Van Zele, Thibaut
    Acke, Frederic
    De Ruyck, Natalie
    Blomme, Katrien
    Sousa, Ana R.
    Marshall, Richard P.
    Bachert, Claus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (05) : 989 - U428
  • [9] Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
    Jeimy, Samira
    Basharat, Pari
    Lovegrove, Fiona
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2019, 15 (1)
  • [10] Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases
    Kychygina, Anna
    Cassagne, Myriam
    Tauber, Marie
    Galiacy, Stephane
    Paul, Carle
    Fournie, Pierre
    Simon, Michel
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 62 (03) : 519 - 533
12